FORMULATIONS WITH ANTI-TUMOUR ACTION
Formulations with anti-tumour action containing defibrotide and at least another active ingredient as active agents.
1 . A formulation containing, as active agents, defibrotide and at least another active ingredient with anti-tumour action.
2 . A formulation according to claim 1 , which is an aqueous solution.
3 . A formulation according to claim 1 , which contains customary excipients and/or adjuvants.
4 . A formulation according to claim 1 , wherein the other active ingredient with anti-tumour action is selected from paclitaxel, monocrotaline, BCNU, and/or cyclophosphamide.
5 . A formulation according to claim 1 , constituted by two distinct formulations that can be administered separately, one containing defibrotide and the other containing the other active ingredient with anti-tumour action.
6 . A formulation according to claim 1 , as a combined preparation for simultaneous, separate, or sequential administration.
7 . A formulation according to claim 1 , wherein defibrotide is obtained by extraction from animal and/or vegetable tissues.
8 . A formulation according to claim 1 , wherein defibrotide is obtained synthetically.